Washington Institute for Coagulation — Seattle, Washington

Washington Institute for Coagulation is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Washington Institute for Coagulation has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Hemophilia A.

Sponsors: Hoffmann-La Roche, Pfizer, CSL Behring.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington Institute for Coagulation?

Washington Institute for Coagulation has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington Institute for Coagulation conducted?

Washington Institute for Coagulation has 6 clinical trials on record, with 2 currently active. Their work covers Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Hemophilia A.

Is Washington Institute for Coagulation accredited by Crixeo Health?

Washington Institute for Coagulation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington Institute for Coagulation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.